These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 2572230)

  • 1. Anti-CD4 antibody treatment of patients with rheumatoid arthritis: I. Effect on clinical course and circulating T cells.
    Herzog C; Walker C; Müller W; Rieber P; Reiter C; Riethmüller G; Wassmer P; Stockinger H; Madic O; Pichler WJ
    J Autoimmun; 1989 Oct; 2(5):627-42. PubMed ID: 2572230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of rheumatoid arthritis with an anti-CD4 monoclonal antibody.
    Horneff G; Burmester GR; Emmrich F; Kalden JR
    Arthritis Rheum; 1991 Feb; 34(2):129-40. PubMed ID: 1994909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of rheumatoid arthritis with monoclonal CD4 antibody M-T151. Clinical results and immunopharmacologic effects in an open study, including repeated administration.
    Reiter C; Kakavand B; Rieber EP; Schattenkirchner M; Riethmüller G; Krüger K
    Arthritis Rheum; 1991 May; 34(5):525-36. PubMed ID: 2025306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunological effects of high dose administration of anti-CD4 antibody in rheumatoid arthritis patients.
    Goldberg D; Morel P; Chatenoud L; Boitard C; Menkes CJ; Bertoye PH; Revillard JP; Bach JF
    J Autoimmun; 1991 Aug; 4(4):617-30. PubMed ID: 1777012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-CD4 antibody treatment of patients with rheumatoid arthritis: II. Effect of in vivo treatment on in vitro proliferative response of CD4 cells.
    Walker C; Herzog C; Rieber P; Riethmüller G; Müller W; Pichler WJ
    J Autoimmun; 1989 Oct; 2(5):643-9. PubMed ID: 2572231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An anti-CD4 antibody for treatment of chronic inflammatory arthritis.
    Emmrich F; Horneff G; Becker W; Lüke W; Potocnik A; Kanzy U; Kalden JR; Burmester G
    Agents Actions Suppl; 1991; 32():165-70. PubMed ID: 2069085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunological follow-up of 17 patients with rheumatoid arthritis treated in vivo with an anti-T CD4+ monoclonal antibody (B-F5).
    Racadot E; Wijdenes J; Wendling D
    Clin Exp Rheumatol; 1992; 10(4):365-74. PubMed ID: 1356679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of anti-CD4 antibody treatment on inflammatory arthritis in MRL-lpr/lpr mice.
    Gilkeson GS; Spurney R; Coffman TM; Kurlander R; Ruiz P; Pisetsky DS
    Clin Immunol Immunopathol; 1992 Aug; 64(2):166-72. PubMed ID: 1353712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in immunotherapy of rheumatoid arthritis: clinical and immunological findings following treatment with anti-CD4 antibodies.
    Horneff G; Emmrich F; Burmester GR
    Br J Rheumatol; 1993 Jun; 32 Suppl 4():39-47. PubMed ID: 8099518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of rheumatoid arthritis with single dose or weekly pulses of chimaeric anti-CD4 monoclonal antibody.
    Choy EH; Chikanza IC; Kingsley GH; Corrigall V; Panayi GS
    Scand J Immunol; 1992 Aug; 36(2):291-8. PubMed ID: 1354392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pharmacokinetics and human anti-mouse antibody response in rheumatoid arthritis patients treated with a chimeric anti-CD4 monoclonal antibody.
    Choy EH; Schantz A; Pitzalis C; Kingsley GH; Panayi GS
    Br J Rheumatol; 1998 Jul; 37(7):801-2. PubMed ID: 9714366
    [No Abstract]   [Full Text] [Related]  

  • 12. Experience with a chimeric monoclonal anti-CD4 antibody in the treatment of refractory rheumatoid arthritis.
    Moreland LW; Pratt PW; Sanders ME; Koopman WJ
    Clin Exp Rheumatol; 1993; 11 Suppl 8():S153-9. PubMed ID: 8100752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of a chimeric monoclonal anti-CD4 antibody in patients with refractory rheumatoid arthritis.
    Moreland LW; Bucy RP; Tilden A; Pratt PW; LoBuglio AF; Khazaeli M; Everson MP; Daddona P; Ghrayeb J; Kilgarriff C
    Arthritis Rheum; 1993 Mar; 36(3):307-18. PubMed ID: 8095785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-CD4 monoclonal antibody therapy in human autoimmune diseases.
    Schulze-Koops H; Lipsky PE
    Curr Dir Autoimmun; 2000; 2():24-49. PubMed ID: 11791458
    [No Abstract]   [Full Text] [Related]  

  • 15. Monoclonal antibodies to CD4.
    Breedveld FC
    Rheum Dis Clin North Am; 1998 Aug; 24(3):567-78. PubMed ID: 9710887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of intra-articular primatised anti-CD4 in resistant rheumatoid knees.
    Smith M
    Ann Rheum Dis; 2000 May; 59(5):398-9. PubMed ID: 10836958
    [No Abstract]   [Full Text] [Related]  

  • 17. Anti-CD4 therapy in rheumatoid arthritis.
    Burmester GR; Emmrich F
    Clin Exp Rheumatol; 1993; 11 Suppl 8():S139-45. PubMed ID: 8100750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human anti-mouse antibody response induced by anti-CD4 monoclonal antibody therapy in patients with rheumatoid arthritis.
    Horneff G; Winkler T; Kalden JR; Emmrich F; Burmester GR
    Clin Immunol Immunopathol; 1991 Apr; 59(1):89-103. PubMed ID: 2019013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment with a chimeric CD4 monoclonal antibody is associated with a relative loss of CD4+/CD45RA+ cells in patients with rheumatoid arthritis.
    van der Lubbe PA; Breedveld FC; Tak PP; Schantz A; Woody J; Miltenburg AM
    J Autoimmun; 1997 Feb; 10(1):87-97. PubMed ID: 9080303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction of synovial inflammation after anti-CD4 monoclonal antibody treatment in early rheumatoid arthritis.
    Tak PP; van der Lubbe PA; Cauli A; Daha MR; Smeets TJ; Kluin PM; Meinders AE; Yanni G; Panayi GS; Breedveld FC
    Arthritis Rheum; 1995 Oct; 38(10):1457-65. PubMed ID: 7575695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.